Conversation with The Cancer Letter Brian Druker steps down as CEO of OHSU Knight Cancer Center December 06, 2024Vol.50 No.45By Paul Goldberg
NCI NCI paylines to drop to 9th percentile amid CRs and uncertainty December 06, 2024Vol.50 No.45By Jacquelyn Cobb
News Analysis What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted researchFormer FDA Commissioner Scott Gottlieb expresses “deep concerns” December 06, 2024Vol.50 No.45By Claire Marie Porter
FreeGuest Editorial An elephant in the room: Grief in young adults with cancer December 06, 2024Vol.50 No.45By Casey Walsh
FreeIn the Archives A look back: The National Cancer Act, signed into law 53 years ago December 06, 2024Vol.50 No.45
Capitol Hill As Trump’s second term nears, Republican support for NIH is at a low pointBy stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research November 22, 2024Vol.50 No.44By Paul Goldberg
Patient navigation benefits health systems, improves careInitial data presented at the White House come a year after CMS payment began November 22, 2024Vol.50 No.44By Jacquelyn Cobb
Health Equity Cedars-Sinai spearheads first national certification program for COE staff at cancer centers November 22, 2024Vol.50 No.44By McKenzie Prillaman
Trials & Tribulations Menin inhibitors emerge as new treatment for advanced AML November 22, 2024Vol.50 No.44By Ghayas Issa
